BTK and diffuse large B-cell lymphoma: In contrast to the synergistic effects observed for instance by the combination of BTK and PI3K-AKT inhibitors [24], BTK and MALT1 co-treatment yielded additive effects on MALT1 activity and killing of CD79 mutant ABC DLBCL cells.